Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences

• US 5,268,266 A
• Filed: 06/09/1986
• Issued: 12/07/1993
• Est. Priority Date: 05/07/1984
• Status: Expired due to Fees

• Current Assignee: Genetics Institute LLC (Pfizer Inc.)
• Original Assignee: Genetics Institute LLC (Pfizer Inc.)
• Inventors: Fritsch, Edward F., Collins, Mary
• Primary Examiner(s): NOT, DEFINED
• Assistant Examiner(s): Chambers, Scott A.
• Application Number:
  US06/938,201
• Time in Patent Office: 2,738 Days
• Field of Search: 435/6
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6813 Hybridisation assays
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/683 involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
• CPC Class Codes: C12Q 1/6832 Enhancement of hybridisation reaction
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Abstract

A nucleic acid construct useful in preparing reagents for determining target nucleotide sequences in the nucleic acid of a biological sample, the construct having in its single-stranded form:

(a) a target binding region substantially complementary to the target nucleotide sequence, and

(b) a signal strand pairing segment bound in the construct by complementary base pairing to a portion of the target binding region;

a second portion of the target binding region being single-stranded; and

the target binding region and signal strand pairing segment being covalently linked by a phosphate/sugar backbone.

A replicable nucleic acid having an origin of replication and two half-restriction sites capable of forming a restriction site can be treated with a restriction enzyme to form a length of nucleic acid containing the target binding region and the signal strand pairing segment. Subsequent labeling of the construct and various optional cleavage and derivation steps can convert the construct to a reagent complex.

Claims

1. A process for preparing a reagent complex for determing a target nucleotide sequence in the nucleic acid of a biological sample, which process comprises the steps:

(a) producing by replication a continuous nucleic acid molecule predominantly in single-stranded form having;

(i) a target binding region substantially complementary to the target nucleotide sequence, and

(ii) a signal strand pairing segment bound by complementary base pairing to a portion of the target binding region;

a second portion of the target binding region being single-stranded, and the target binding region and signal strand pairing segment being covalently linked by a phosphate-sugar backbone;

(b) forming a first terminus adjacent to the signal strand pairing segment and a second terminus adjacent to the target binding region, with a nucleic acid strand including the target binding region and signal strand pairing segment extending from the first terminus to the second terminus; and

(c) attaching a detectable tag to the nucleic acid strand having the target binding region, the signal strand pairing segment, the first terminus and the second terminus.

2. The process of claim 1 wherein the detectable tag is attached to a terminus adjacent to the signal strand pairing segment.

3. The process of claim 2 further comprising the step:

(d) cleaving the phosphate-sugar backbone covalent linkage of the signal strand pairing segment to the target binding region, while retaining the complementary base pair binding between the signal strand pairing segment and a portion of the target binding region.

4. The process of claim 3 further comprising the step:

(e) attaching an end of the nucleic acid molecule adjacent to the target binding region to a solid support.

5. The process of claim 4 wherein the attaching step (e) precedes the cleaving step (d) and the end attached is distal from the signal strand pairing segment.

6. The process of claim 4 wherein the attaching step (e) follows the cleaving step (d) and the end attached is created by the cleaving step (d).

7. The process of claim 2 further comprising the step:

(d) attaching a moiety to the nucleic acid molecule at a terminus adjacent to the target binding region, the moiety being immobilizable by an affinity reagent.

8. The process of claim 2 wherein the first terminus and second terminus created in forming step (b) are a 3'"'"' end and a 5'"'"' end, and the attaching step (c) comprises selectively attaching the detectable tag to the first terminus.

9. The process of claim 8 wherein the first terminus is a 3'"'"' end and the attaching step (c) comprising elongating the 3'"'"' end with detectable nucleotides.

10. The process of claim 8 wherein the second terminus is a 5'"'"' end and the process further comprises attaching the 5'"'"' end to a solid support.

11. The process of claim 8 wherein the second terminus is a 5'"'"' end and the process further comprises attaching the 5'"'"' end to a moiety which is immobilizable by an affinity reagent.

12. The process of claim 1 wherein the detectable tag is attached to a terminus adjacent to the target binding region.